Company Overview of HemaQuest Pharmaceuticals, Inc.
HemaQuest Pharmaceuticals, Inc., a pharmaceutical company, develops small molecule therapeutics based on its short chain fatty acid derivative (SCFAD) technologies to treat anemia and other blood disorders. Its products include Hydroxyurea, a therapeutic agent for the treatment of underlying pathology of sickle cell anemia; and for the treatments of beta thalassemia, sickle cell anemia, neutropenia, and various hematological disorders. The company was formerly known as Hemagenex Pharmaceuticals, Inc. and changed its name in 2008. HemaQuest Pharmaceuticals, Inc. was founded in 2007 and is based in San Diego, California.
11995 El Camino Real
San Diego, CA 92130
Founded in 2007
Key Executives for HemaQuest Pharmaceuticals, Inc.
HemaQuest Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|Cera Products, Inc.||United States|
|Pfizer Pharmaceuticals Inc.||United States|
|Regional Nuclear Pharmaceuticals Inc.||United States|
|Intervet Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact HemaQuest Pharmaceuticals, Inc., please visit www.hemaquest.com. Company data is provided by Capital IQ. Please use this form to report any data issues.